Endpoints News

1 week ago | endpts.com | Nicole DeFeudis

The UK on Thursday authorized GSK’s Blenrep to treat certain multiple myeloma patients in two different regimens, marking the drug’s first approval worldwide since it …Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

1 week ago | endpts.com | Anna Brown

Roughly 85% of the brand-name drugs prescribed in the US rely on ingredients sourced from other countries, according to a new report issued ahead of …Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

1 week ago | endpts.com | Lydia Ramsey Pflanzer

This week, Walgreens revealed how its take-private deal came together. Here are some of the biggest takeaways from theSign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

1 week ago | endpts.com | Anna Brown

Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and more. Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

1 week ago | endpts.com | Ngai Yeung

UnitedHealth Group reported disappointing first-quarter earnings and cut its financial guidance, hit by high costs in its Medicare Advantage business. Though the insurer did not … Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.